Results

Total Results: 2,245 records

Showing results for "determine".

2221. Disposition of Comments for CER 181 Mental Health Care (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mental-health-children_disposition-comments.pdf
      December 19, 2016 - Disposition of Comments for CER 181 Mental Health Care Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/ ?pageaction=displayproduct&productid=2372 Published Online: December 19, 2016 Comparative Effectiveness Review Disposition of Comments Report Research Revie…

2222. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
      January 24, 2022 - KQ1_IgG Duration_n=3 Observational studies examining IgG Duration Author Year Title PMID Link/URL Country Study Design Length of follow-up (Months) Population category Population Description Data Source Study Period Inclusion criteria Exclusion criteria Total N Age: Mean (SD) years or Median (IQR) Race stratifi…

2223. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting_research-protocol.pdf
      August 19, 2011 - physiologic and angiographic assessments of the severity of stenosis, often making it difficult to determine … Fractional flow reserve (FFR), in contrast, is an IVDx technique used to determine the physiologic significance

2224. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
      June 01, 2022 - objective of this update is to identify the latest evidence published since the 2020 report and to determine

2225. Attention Deficit Hyperactivity Disorder: Executive Summary (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/adhd_executive.pdf
      October 01, 2011 - Attention Deficit Hyperactivity Disorder: Executive Summary                                                                                                                                                                                                                                                       …

2226. Disposition of Comments CER 185 Tympanostomy Tubes in Children With Otitis Media (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
      May 05, 2017 - Disposition of Comments CER 185 Tympanostomy Tubes in Children With Otitis Media Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Tympanostomy Tubes in Children With Otitis Media Draft review available for public comment from July 20, 2016 to August 11, 2016. R…

2227. Disposition of Comments CER 185 Tympanostomy Tubes in Children With Otitis Media (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
      May 05, 2017 - Disposition of Comments CER 185 Tympanostomy Tubes in Children With Otitis Media Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Tympanostomy Tubes in Children With Otitis Media Draft review available for public comment from July 20, 2016 to August 11, 2016. R…

2228. Weight-Gain-Prevention Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
      January 01, 2020 - 1 Comparative Effectiveness Review Number 97 Strategies To Prevent Weight Gain Among Adults Executive Summary Background Condition One of the Healthy People 2020 national objectives is to increase the prevalence of a healthy weight among adults to 34 percent and to reduce the prevalence of obesity amon…

2229. Disposition of Comments Report for Treatment of Atrial Fibrillation (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_disposition-comments.pdf
      June 28, 2013 - any more due to risk of PV stenosis), and each of these may or may not include formal testing to determine

2230. Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard (ppt file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-meta-analysis.ppt
      June 01, 2012 - Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard Meta-analysis of Test Performance When There Is a “Gold Standard” Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Medical Test Reviews Methods Guide www.ahrq.gov Meta-analysis of T…

2231. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
      December 31, 2022 - Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review Rapid Evidence Product Version 3.0 (July 2022) Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review What Di…

2232. Topic Brief: Interventions to Decrease Hospital Length of Stay (pdf file)
      effectivehealthcare-admin.ahrq.gov/system/files/docs/topic-brief-hospital-length-of-stay.pdf
      November 01, 2019 - Topic Brief: Interventions to Decrease Hospital Length of Stay 1 Topic Brief: Interventions to Decrease Hospital Length of Stay Date: 8/6/2019 Nomination Number: 866 Purpose: This document summarizes the information addressing a nomination submitted on 6/28/2019 through the Effective Health Care Web…

2233. Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard (ppt file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-meta-analysis.ppt
      June 01, 2012 - Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard Meta-analysis of Test Performance When There Is a “Gold Standard” Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Medical Test Reviews Methods Guide www.ahrq.gov Meta-analysis of T…

2234. Interventions To Decrease Hospital Length of Stay | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/hospital-length-of-stay/report
      March 01, 2022 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

2235. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
      January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…

2236. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
      January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…

2237. Ace-Inhibitor-Arb-Update-Surveillance-160328 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update-surveillance-160328.pdf
      March 28, 2016 - AHRQ%Systematic%Review%Surveillance% Program% " CER$#34:$Angiotensin"Converting"Enzyme"Inhibitors" (ACEIs),"Angiotensin"II"Receptor"Antagonists"(ARBs)," and"Direct"Renin"Inhibitors"for"Treating"Essential" Hypertension"–"An"Update"" $ $ Original$Release$Date:$June"2011""" Surveillance$Report$Date:$March"2…

2238. Crohns-Disease Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
      February 01, 2014 - 1 Comparative Effectiveness Review Number 131 Pharmacologic Therapies for the Management of Crohn’s Disease: Comparative Effectiveness Executive Summary Description of Crohn’s Disease Crohn’s disease is a type of inflammatory bowel disease. Other types of inflammatory bowel disease include ulcerative colitis a…

2239. Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
      October 01, 2022 - Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review Rapid Evidence Product Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: …

2240. Fiber-Intake-Draft-Report-Appendix-C (xls file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fiber-intake-draft-report-appendix-c.xlsx
      January 01, 2024 - Design Details Author, Year, PMID, Country, Registry Number Study design Study Years Funding Conflict of interest (COI) Setting Inclusion criteria Exclusion criteria Durationofintervention Washout period N Outcome measurements/time period Outcome measurement timing Alexander (1) 2023 U.S 36102329 RCT cross-over < …